论文部分内容阅读
糖尿病肾病(diabetic nephropathy,DN)是糖尿病(DM)的主要微血管并发症,在西方(美国)是终末期肾病(end-stage renal disease,ESRD)的最主要原因,约占38%,我国由DN造成的ESRD亦逐年上升。我们对32例2型糖尿病DN患者在饮食、血糖及血压控制基础上应用川芎嗪注射液联合低分子肝素
Diabetic nephropathy (DN) is a major microvascular complication of diabetes mellitus (DM) and is the leading cause of end-stage renal disease (ESRD) in the West (about 38%). Our country consists of DN The resulting ESRD also increased year by year. We 32 cases of DN patients with type 2 diabetes diet, blood glucose and blood pressure control based on the application of ligustrazine injection combined with low molecular weight heparin